Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: A phase III studyAVRIL, M. F; AAMDAL, S; PORTA, V. Guillem et al.Journal of clinical oncology. 2004, Vol 22, Num 6, pp 1118-1125, issn 0732-183X, 8 p.Article

Alterations of DNA repair in melanoma cell lines resistant to cisplatin, fotemustine, or etoposideRÜNGER, T. M; EMMERT, S; SCHADENDORF, D et al.Journal of investigative dermatology. 2000, Vol 114, Num 1, pp 34-39, issn 0022-202XConference Paper

Antitumor effects of fotemustine and busulfan against a human neuroblastoma xenograftIKEDA, Hitoshi; TSUCHIDA, Yoshiaki; JIANGUO WU et al.Oncology reports. 2000, Vol 7, Num 6, pp 1265-1268, issn 1021-335XArticle

Fotemustine and interferon α2b in metastatic malignant melanomaWEICHENTHAL, M; MOHR, P; STEPHAN, U et al.Journal of cancer research and clinical oncology. 1998, Vol 124, Num 1, pp 55-59, issn 0171-5216Article

Stability study of fotemustine in PVC infusion bags and sets under various conditions using a stability-indicating high-performance liquid chromatographic assayDINE, T; KHALFI, F; GRESSIER, B et al.Journal of pharmaceutical and biomedical analysis. 1998, Vol 18, Num 3, pp 373-381, issn 0731-7085Article

Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trialLEYVRAZ, S; PIPERNO-NEUMANN, S; VERMORKEN, J. B et al.Annals of oncology. 2014, Vol 25, Num 3, pp 742-746, issn 0923-7534, 5 p.Article

Antimutagenicity of amifostine against the anticancer drug fotemustine in the Drosophila somatic mutation and recombination (SMART) testAYDEMIR, N; SEVIM, N; CELIKLER, S et al.Mutation research. Genetic toxicology and environmental mutagenesis (Print). 2009, Vol 679, Num 1-2, pp 1-5, issn 1383-5718, 5 p.Article

Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiformeFAZENY-DÖRNER, B; VEITL, M; WENZEL, C et al.British journal of cancer. 2003, Vol 88, Num 4, pp 496-501, issn 0007-0920, 6 p.Article

Cisplatin, dacarbazine, and fotemustine plus interferon a in patients with advanced malignant melanoma: A multicenter Phase II study of the Southern Italy Cooperative Oncology GroupDAPONTE, Antonio; ASCIERTO, Paolo A; GRAVINA, Adriano et al.Cancer. 2000, Vol 89, Num 12, pp 2630-2636, issn 0008-543XArticle

Phase I pharmacological study of intra-arterially infused fotemustine for colorectal liver metastasesHARTMANN, J. T; SCHMOLL, E; BOKEMEYER, C et al.European journal of cancer (1990). 1998, Vol 34, Num 1, pp 87-91, issn 0959-8049Article

Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapyLEYVRAZ, S; SPATARO, V; BAUER, J et al.Journal of clinical oncology. 1997, Vol 15, Num 7, pp 2589-2595, issn 0732-183XArticle

Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide : Modulation of proto-oncogene expressionKERN, M. A; HELMBACH, H; ARTUC, M et al.Anticancer research. 1997, Vol 17, Num 6D, pp 4359-4370, issn 0250-7005Article

Fotemustine Chemoembolization of Hepatic Metastases From Uveal Melanoma: A Retrospective Single-Center AnalysisEDELHAUSER, Gundula; SCHICHER, Nikolaus; BERZACZY, Dominik et al.American journal of roentgenology (1976). 2012, Vol 199, Num 6, pp 1387-1392, issn 0361-803X, 6 p.Article

Cisplatin, fotemustine and whole-brain radiotherapy in non-small cell lung cancer patients with asymptomatic brain metastases: A multicenter phase II study of the Gruppo Oncologico Italia Meridionale (GOIM 2603)GALETTA, D; GEBBIA, V; SILVESTRIS, N et al.Lung cancer. 2011, Vol 72, Num 1, pp 59-63, issn 0169-5002, 5 p.Article

Bevacizumab plus Fotemustine as First-line Treatment in Metastatic Melanoma Patients: Clinical Activity and Modulation of Angiogenesis and Lymphangiogenesis FactorsDEL VECCHIO, Michele; MORTARINI, Roberta; BAJETTA, Emilio et al.Clinical cancer research (Print). 2010, Vol 16, Num 23, pp 5862-5872, issn 1078-0432, 11 p.Article

Infrequent promoter methylation of the MGMT gene in liver metastases from uveal melanomaVOELTER, Verena; DISERENS, Annie-Claire; HEGI, Monika E et al.International journal of cancer. 2008, Vol 123, Num 5, pp 1215-1218, issn 0020-7136, 4 p.Article

Temozolomide in combination with fotemustine in patients with metastatic melanomaTAS, Faruk; CAMLICA, Hakan; TOPUZ, Erkan et al.Cancer chemotherapy and pharmacology. 2008, Vol 62, Num 2, pp 293-298, issn 0344-5704, 6 p.Article

Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer GroupAAPRO, M. S; VAN WIJK, F. H; SPLINTER, T. E. W et al.European journal of cancer (1990). 2003, Vol 39, Num 8, pp 1141-1143, issn 0959-8049, 3 p.Article

Treatment of disseminated ocular melanoma with sequential fotemustine, interferon α, and interleukin 2BECKER, J. C; TERHEYDEN, P; KÄMPGEN, E et al.British journal of cancer. 2002, Vol 87, Num 8, pp 840-845, issn 0007-0920, 6 p.Article

Modulation of DNA topoisomerase II activity and expression in melanoma cells with acquired drug resistanceLAGE, H; HELMBACH, H; DIETEL, M et al.British journal of cancer. 2000, Vol 82, Num 2, pp 488-491, issn 0007-0920Article

Sequential administration of temozolomide and fotemustine : Depletion of O6-alkyl guanine-DNA transferase in blood lymphocytes and in tumoursGANDER, M; LEYVRAZ, S; LEJEUNE, F et al.Annals of oncology. 1999, Vol 10, Num 7, pp 831-838, issn 0923-7534Article

Nouvelle toxicité de la fotémustine: une pneumopathie interstitielle diffuse = New toxicity of fotemustine: Diffuse interstitial lung diseaseBERTRAND, M; WEMEAU-STERVINOU, L; GAUTHIER, S et al.Annales de dermatologie et de vénéréologie. 2012, Vol 139, Num 4, pp 277-281, issn 0151-9638, 5 p.Article

Functional and morphological effects of fotemustine on the auditory system of the ratGOCER, C; ERYILMAZ, A; KAYIKCI, M. E. Kulak et al.Journal of laryngology and otology. 2008, Vol 122, Num 6, pp 551-556, issn 0022-2151, 6 p.Article

Artesunate in the treatment of metastatic uveal melanoma : first experiencesBERGER, Thomas G; DIECKMANN, Detlef; EFFERTH, Thomas et al.Oncology reports. 2005, Vol 14, Num 6, pp 1599-1603, issn 1021-335X, 5 p.Article

Fotemustine combined with procarbazine in recurrent malignant gliomas : a phase I study with evaluation of lymphocyte O⁶-alkylguanine-DNA alkyltransferase activityBOIARDI, Amerigo; SILVANI, Antonio; CIUSANI, Emilio et al.Journal of neuro-oncology. 2001, Vol 52, Num 2, pp 149-156, issn 0167-594XArticle